Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 26, 2024PharmaceuticalsOpen Access

Pharmacovigilance Practices by Healthcare Providers in Oncology: A Cross-Sectional Study

View Full Paper
Ask AI
Bookmark
Share

Authors

HAHadeel AlkofideKing Saud UniversityHAHaya M. AlmalagKing Saud UniversityMAMashael Alromaih

Discussion

Loading...

Member takes

Implication

Cross-sectional study reveals gaps in adverse drug reaction review procedures among oncology healthcare providers, highlighting the need for standardized pharmacovigilance education.

Key Points

  • Adverse drug reaction reporting remains hindered by complex cancer regimens, with methotrexate and paclitaxel identified as the primary agents causing toxicities.
  • Internally, 58.9% of surveyed oncology providers reported adverse drug reactions, yet only 38.5% recognized formal review protocols despite high prior education.
  • Cross-sectional survey data reveal that reinforcing targeted pharmacovigilance education and establishing unified guidelines are essential to improve patient safety.

Cite This Study

Alkofide et al. (2024) studied this question.

synapsesocial.com/papers/68e685a5b6db64358760ed14https://doi.org/10.3390/ph17060683
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epidemiology of cancer in Saudi Arabia thru 2010–2019: a systematic review with constrained meta-analysis Running title: epidemiology of cancer in Saudi Arabia thru 2010–20192020 · 140 citations
  2. 2Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability2019 · 72 citations
  3. 3Chemotherapy-induced adverse drug reactions in oncology patients: A prospective observational survey2016 · 135 citations
  4. 4The Impact of Electronic Health Record Interoperability on Safety and Quality of Care in High-Income Countries: Systematic Review2022 · 225 citations
  5. 5Pharmacovigilance in oncology2018 · 78 citations